

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.65380490 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.35200927 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.35200927 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.15178869 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.65474242 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.32597628 |
| 7 | negative T cell selection (GO:0043383) | 4.31996709 |
| 8 | definitive hemopoiesis (GO:0060216) | 4.28080274 |
| 9 | negative thymic T cell selection (GO:0045060) | 4.25381678 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 4.22455013 |
| 11 | interferon-gamma production (GO:0032609) | 4.15936980 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.06081364 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 3.93832244 |
| 14 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.89822209 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.84186623 |
| 16 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.83333920 |
| 17 | positive thymic T cell selection (GO:0045059) | 3.78289718 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 3.77830758 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.75921370 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.75921370 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 3.67215476 |
| 22 | megakaryocyte development (GO:0035855) | 3.65053285 |
| 23 | regulation of B cell differentiation (GO:0045577) | 3.64223427 |
| 24 | detection of other organism (GO:0098543) | 3.62090523 |
| 25 | microglial cell activation (GO:0001774) | 3.51679896 |
| 26 | thymic T cell selection (GO:0045061) | 3.49643389 |
| 27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.47231453 |
| 28 | T cell selection (GO:0045058) | 3.46468635 |
| 29 | detection of external biotic stimulus (GO:0098581) | 3.38507450 |
| 30 | leukocyte aggregation (GO:0070486) | 3.38057764 |
| 31 | negative regulation of phagocytosis (GO:0050765) | 3.37254739 |
| 32 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.34412895 |
| 33 | response to interleukin-15 (GO:0070672) | 3.34368589 |
| 34 | histone H3-K36 demethylation (GO:0070544) | 3.32069417 |
| 35 | negative regulation of T cell mediated immunity (GO:0002710) | 3.30838368 |
| 36 | positive T cell selection (GO:0043368) | 3.30618170 |
| 37 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29730078 |
| 38 | detection of bacterium (GO:0016045) | 3.29601006 |
| 39 | positive regulation of granulocyte differentiation (GO:0030854) | 3.25002174 |
| 40 | positive regulation of interleukin-2 production (GO:0032743) | 3.23877861 |
| 41 | response to muramyl dipeptide (GO:0032495) | 3.23085071 |
| 42 | T cell migration (GO:0072678) | 3.18773470 |
| 43 | myeloid dendritic cell activation (GO:0001773) | 3.18304114 |
| 44 | macrophage activation (GO:0042116) | 3.18264539 |
| 45 | activated T cell proliferation (GO:0050798) | 3.17960985 |
| 46 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.16992117 |
| 47 | cellular response to ethanol (GO:0071361) | 3.14353346 |
| 48 | positive regulation of isotype switching (GO:0045830) | 3.14007783 |
| 49 | response to type I interferon (GO:0034340) | 3.13389944 |
| 50 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.08995159 |
| 51 | cellular response to interleukin-15 (GO:0071350) | 3.08275526 |
| 52 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.07561709 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 3.06944355 |
| 54 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.04868637 |
| 55 | B cell receptor signaling pathway (GO:0050853) | 3.04364694 |
| 56 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.03965173 |
| 57 | cellular response to type I interferon (GO:0071357) | 3.03004480 |
| 58 | type I interferon signaling pathway (GO:0060337) | 3.03004480 |
| 59 | detection of biotic stimulus (GO:0009595) | 3.01517588 |
| 60 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.01449556 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 3.00004697 |
| 62 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.97777402 |
| 63 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.95908779 |
| 64 | response to host immune response (GO:0052572) | 2.95908779 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.93450917 |
| 66 | regulation of necroptotic process (GO:0060544) | 2.92585479 |
| 67 | response to host (GO:0075136) | 2.92258955 |
| 68 | response to host defenses (GO:0052200) | 2.92258955 |
| 69 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.92258955 |
| 70 | neutrophil mediated immunity (GO:0002446) | 2.91656094 |
| 71 | histone H3-K4 trimethylation (GO:0080182) | 2.89863363 |
| 72 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89061814 |
| 73 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.88163821 |
| 74 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.87746950 |
| 75 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86875225 |
| 76 | positive regulation of interferon-alpha production (GO:0032727) | 2.86558351 |
| 77 | tolerance induction (GO:0002507) | 2.86253767 |
| 78 | neutrophil activation (GO:0042119) | 2.81554058 |
| 79 | myeloid cell activation involved in immune response (GO:0002275) | 2.81416603 |
| 80 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79834095 |
| 81 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.79414488 |
| 82 | regulation of interferon-alpha production (GO:0032647) | 2.78723251 |
| 83 | angiogenesis involved in wound healing (GO:0060055) | 2.77808139 |
| 84 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.77339540 |
| 85 | response to protozoan (GO:0001562) | 2.77011206 |
| 86 | hepatocyte apoptotic process (GO:0097284) | 2.75291510 |
| 87 | regulation of response to interferon-gamma (GO:0060330) | 2.74107300 |
| 88 | germinal center formation (GO:0002467) | 2.73476465 |
| 89 | positive regulation of DNA recombination (GO:0045911) | 2.73007947 |
| 90 | natural killer cell activation (GO:0030101) | 2.73004820 |
| 91 | lymph node development (GO:0048535) | 2.72627626 |
| 92 | cellular extravasation (GO:0045123) | 2.72303309 |
| 93 | cellular response to zinc ion (GO:0071294) | 2.71841564 |
| 94 | negative regulation of B cell proliferation (GO:0030889) | 2.71591271 |
| 95 | defense response to protozoan (GO:0042832) | 2.70712115 |
| 96 | myeloid leukocyte mediated immunity (GO:0002444) | 2.69764131 |
| 97 | neutrophil activation involved in immune response (GO:0002283) | 2.69666519 |
| 98 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.69413520 |
| 99 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.69413520 |
| 100 | mast cell activation (GO:0045576) | 2.68971212 |
| 101 | T cell homeostasis (GO:0043029) | 2.68777036 |
| 102 | myeloid dendritic cell differentiation (GO:0043011) | 2.68655544 |
| 103 | immunoglobulin mediated immune response (GO:0016064) | 2.68137581 |
| 104 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.67956021 |
| 105 | positive regulation of tolerance induction (GO:0002645) | 2.66651433 |
| 106 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.66212151 |
| 107 | response to peptidoglycan (GO:0032494) | 2.66170209 |
| 108 | embryonic hemopoiesis (GO:0035162) | 2.64013374 |
| 109 | positive regulation of antigen processing and presentation (GO:0002579) | 2.63321165 |
| 110 | regulation of tolerance induction (GO:0002643) | 2.63018815 |
| 111 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.62279320 |
| 112 | leukocyte cell-cell adhesion (GO:0007159) | 2.62207791 |
| 113 | alpha-beta T cell activation (GO:0046631) | 2.61865187 |
| 114 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.61566561 |
| 115 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.61466395 |
| 116 | T-helper cell differentiation (GO:0042093) | 2.61466395 |
| 117 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.61108958 |
| 118 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60665120 |
| 119 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.60658233 |
| 120 | positive regulation of B cell mediated immunity (GO:0002714) | 2.60658233 |
| 121 | negative regulation of adaptive immune response (GO:0002820) | 2.59731149 |
| 122 | positive regulation of humoral immune response (GO:0002922) | 2.58205683 |
| 123 | granulocyte activation (GO:0036230) | 2.57926351 |
| 124 | lymphocyte homeostasis (GO:0002260) | 2.57501742 |
| 125 | T cell costimulation (GO:0031295) | 2.57114113 |
| 126 | dendritic cell chemotaxis (GO:0002407) | 2.56722320 |
| 127 | positive regulation of B cell activation (GO:0050871) | 2.56080894 |
| 128 | negative regulation of granulocyte differentiation (GO:0030853) | 2.55118864 |
| 129 | negative regulation of interleukin-12 production (GO:0032695) | 2.54786726 |
| 130 | mature B cell differentiation (GO:0002335) | 2.54742841 |
| 131 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.54515185 |
| 132 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.54515185 |
| 133 | modulation by symbiont of host immune response (GO:0052553) | 2.54515185 |
| 134 | positive regulation by symbiont of host defense response (GO:0052509) | 2.54515185 |
| 135 | modulation by symbiont of host defense response (GO:0052031) | 2.54515185 |
| 136 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.54515185 |
| 137 | dendritic cell migration (GO:0036336) | 2.54149043 |
| 138 | lymphocyte costimulation (GO:0031294) | 2.52858636 |
| 139 | B cell homeostasis (GO:0001782) | 2.50862614 |
| 140 | regulation of granulocyte differentiation (GO:0030852) | 2.49800565 |
| 141 | regulation of B cell proliferation (GO:0030888) | 2.48200419 |
| 142 | regulation of regulatory T cell differentiation (GO:0045589) | 2.46549056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.07262385 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.32011534 |
| 3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.03694851 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.96489646 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.82550754 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.52353218 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.45418810 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.42963733 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.41478519 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.38393068 |
| 11 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.23785587 |
| 12 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.20792944 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.03864942 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.85035474 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82477050 |
| 16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.78024020 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.70850781 |
| 18 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64248358 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.61164310 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.58726206 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.58562068 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.53081230 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.36779028 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.34998721 |
| 25 | MYB_26560356_Chip-Seq_TH1_Human | 2.34076832 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.18938063 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10006947 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.04602477 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.99463380 |
| 30 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.97114083 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.95337449 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93321436 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93263758 |
| 34 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.93042146 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88152509 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86101109 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84615604 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83348055 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79833376 |
| 40 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.71850614 |
| 41 | SPI1_23127762_ChIP-Seq_K562_Human | 1.67525485 |
| 42 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.63296029 |
| 43 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.61562772 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53070031 |
| 45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.52301614 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50800980 |
| 47 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47077686 |
| 48 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.46983506 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42551530 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42212442 |
| 51 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.40926056 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40103194 |
| 53 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.39523655 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38049969 |
| 55 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37866495 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36512508 |
| 57 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36122573 |
| 58 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.31820822 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31493523 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30849405 |
| 61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.28855095 |
| 62 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28265743 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27491992 |
| 64 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.25647430 |
| 65 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24004652 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23861742 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.23573240 |
| 68 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21490154 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.20692713 |
| 70 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19781217 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18983064 |
| 72 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18810355 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18332273 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17274246 |
| 75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.15952842 |
| 76 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14529750 |
| 77 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12391066 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11740636 |
| 79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10646183 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09047267 |
| 81 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08845105 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07654736 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07162640 |
| 84 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99914502 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99754417 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99651645 |
| 87 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99041595 |
| 88 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98891741 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98692338 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98196681 |
| 91 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98128028 |
| 92 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97309063 |
| 93 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97168943 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96587207 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94640443 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94121614 |
| 97 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.94099090 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93355241 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92120862 |
| 100 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.92088433 |
| 101 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91446619 |
| 102 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90102797 |
| 103 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.90031410 |
| 104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.89147097 |
| 105 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.88929290 |
| 106 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88328006 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88212865 |
| 108 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88135680 |
| 109 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.88104316 |
| 110 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.87630863 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86526526 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84425331 |
| 113 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84332839 |
| 114 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84332839 |
| 115 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.83702311 |
| 116 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.83536431 |
| 117 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.83536431 |
| 118 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.82870951 |
| 119 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81210056 |
| 120 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81142293 |
| 121 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.80290262 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.79324104 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78479763 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77569441 |
| 125 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.77491826 |
| 126 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.77285592 |
| 127 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77071112 |
| 128 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.76622085 |
| 129 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75818648 |
| 130 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.75387075 |
| 131 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74286034 |
| 132 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.74110740 |
| 133 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72920911 |
| 134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70061513 |
| 135 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.69374710 |
| 136 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.66800857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.80957989 |
| 2 | MP0005671_abnormal_response_to | 3.11932962 |
| 3 | MP0000685_abnormal_immune_system | 2.96350076 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.93112180 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.88242712 |
| 6 | MP0001800_abnormal_humoral_immune | 2.76658410 |
| 7 | MP0001790_abnormal_immune_system | 2.72668988 |
| 8 | MP0005387_immune_system_phenotype | 2.72668988 |
| 9 | MP0009785_altered_susceptibility_to | 2.62789952 |
| 10 | MP0003436_decreased_susceptibility_to | 2.59373802 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.56060841 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.55441893 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.44583600 |
| 14 | MP0002723_abnormal_immune_serum | 2.34931797 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.30753264 |
| 16 | MP0001819_abnormal_immune_cell | 2.29326189 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.28295733 |
| 18 | MP0005025_abnormal_response_to | 2.26597523 |
| 19 | MP0004808_abnormal_hematopoietic_stem | 2.21036454 |
| 20 | MP0002398_abnormal_bone_marrow | 2.19818192 |
| 21 | MP0003724_increased_susceptibility_to | 2.13589179 |
| 22 | MP0002419_abnormal_innate_immunity | 2.13169144 |
| 23 | MP0002006_tumorigenesis | 2.12871432 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.00807527 |
| 25 | MP0002405_respiratory_system_inflammati | 1.98560983 |
| 26 | MP0000716_abnormal_immune_system | 1.96609306 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.93900920 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.93752550 |
| 29 | MP0005397_hematopoietic_system_phenotyp | 1.92763160 |
| 30 | MP0001545_abnormal_hematopoietic_system | 1.92763160 |
| 31 | MP0004510_myositis | 1.88166507 |
| 32 | MP0001853_heart_inflammation | 1.85178466 |
| 33 | MP0004381_abnormal_hair_follicle | 1.83151026 |
| 34 | MP0009278_abnormal_bone_marrow | 1.82991848 |
| 35 | MP0005451_abnormal_body_composition | 1.82731645 |
| 36 | MP0008260_abnormal_autophagy | 1.82709433 |
| 37 | MP0000689_abnormal_spleen_morphology | 1.79250396 |
| 38 | MP0001873_stomach_inflammation | 1.76983256 |
| 39 | MP0002722_abnormal_immune_system | 1.73072338 |
| 40 | MP0003303_peritoneal_inflammation | 1.71033483 |
| 41 | MP0004883_abnormal_blood_vessel | 1.68609163 |
| 42 | MP0004947_skin_inflammation | 1.68282833 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.67090215 |
| 44 | MP0002429_abnormal_blood_cell | 1.65710586 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.62894377 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.59326992 |
| 47 | MP0006082_CNS_inflammation | 1.57671323 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.55808015 |
| 49 | MP0004084_abnormal_cardiac_muscle | 1.51395360 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.47968217 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.47308106 |
| 52 | MP0004484_altered_response_of | 1.44599110 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.42166066 |
| 54 | MP0008057_abnormal_DNA_replication | 1.40755484 |
| 55 | MP0008004_abnormal_stomach_pH | 1.37136762 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.34340293 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.33902750 |
| 58 | MP0002933_joint_inflammation | 1.32380916 |
| 59 | MP0003866_abnormal_defecation | 1.31515274 |
| 60 | MP0003828_pulmonary_edema | 1.30867445 |
| 61 | MP0001958_emphysema | 1.29418889 |
| 62 | MP0002332_abnormal_exercise_endurance | 1.27008643 |
| 63 | MP0005310_abnormal_salivary_gland | 1.25791188 |
| 64 | MP0005164_abnormal_response_to | 1.25430946 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.22759457 |
| 66 | MP0000858_altered_metastatic_potential | 1.19159958 |
| 67 | MP0000490_abnormal_crypts_of | 1.16399218 |
| 68 | MP0002009_preneoplasia | 1.16360932 |
| 69 | MP0004036_abnormal_muscle_relaxation | 1.15766272 |
| 70 | MP0003448_altered_tumor_morphology | 1.13414497 |
| 71 | MP0004130_abnormal_muscle_cell | 1.12129841 |
| 72 | MP0003943_abnormal_hepatobiliary_system | 1.10793637 |
| 73 | MP0008469_abnormal_protein_level | 1.10793626 |
| 74 | MP0006054_spinal_hemorrhage | 1.09941435 |
| 75 | MP0003183_abnormal_peptide_metabolism | 1.06745735 |
| 76 | MP0003566_abnormal_cell_adhesion | 1.06374035 |
| 77 | MP0002998_abnormal_bone_remodeling | 1.05603158 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 1.03646635 |
| 79 | MP0003279_aneurysm | 1.02101681 |
| 80 | MP0003045_fibrosis | 1.01717053 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 1.00026278 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.99014787 |
| 83 | MP0009764_decreased_sensitivity_to | 0.96665515 |
| 84 | MP0003646_muscle_fatigue | 0.95515157 |
| 85 | MP0003690_abnormal_glial_cell | 0.92893431 |
| 86 | MP0000343_altered_response_to | 0.92788444 |
| 87 | MP0005076_abnormal_cell_differentiation | 0.89602332 |
| 88 | MP0000767_abnormal_smooth_muscle | 0.87802185 |
| 89 | MP0009115_abnormal_fat_cell | 0.87584003 |
| 90 | MP0002928_abnormal_bile_duct | 0.87382642 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.85412510 |
| 92 | MP0004264_abnormal_extraembryonic_tissu | 0.85246632 |
| 93 | MP0002019_abnormal_tumor_incidence | 0.84587290 |
| 94 | MP0005388_respiratory_system_phenotype | 0.84329858 |
| 95 | MP0002133_abnormal_respiratory_system | 0.84329858 |
| 96 | MP0005390_skeleton_phenotype | 0.79347563 |
| 97 | MP0005023_abnormal_wound_healing | 0.78549451 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.77998839 |
| 99 | MP0003191_abnormal_cellular_cholesterol | 0.77084978 |
| 100 | MP0002168_other_aberrant_phenotype | 0.76914412 |
| 101 | MP0005409_darkened_coat_color | 0.76734895 |
| 102 | MP0005166_decreased_susceptibility_to | 0.76588148 |
| 103 | MP0001851_eye_inflammation | 0.76574447 |
| 104 | MP0000249_abnormal_blood_vessel | 0.75004217 |
| 105 | MP0002095_abnormal_skin_pigmentation | 0.74165804 |
| 106 | MP0003091_abnormal_cell_migration | 0.73693088 |
| 107 | MP0000371_diluted_coat_color | 0.73445694 |
| 108 | MP0008007_abnormal_cellular_replicative | 0.73247383 |
| 109 | MP0002254_reproductive_system_inflammat | 0.72579103 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.71919461 |
| 111 | MP0010307_abnormal_tumor_latency | 0.71857872 |
| 112 | MP0006138_congestive_heart_failure | 0.71200522 |
| 113 | MP0004782_abnormal_surfactant_physiolog | 0.70496572 |
| 114 | MP0003795_abnormal_bone_structure | 0.69431189 |
| 115 | MP0010630_abnormal_cardiac_muscle | 0.69409033 |
| 116 | MP0009763_increased_sensitivity_to | 0.68999270 |
| 117 | MP0002132_abnormal_respiratory_system | 0.68365249 |
| 118 | MP0008961_abnormal_basal_metabolism | 0.68026303 |
| 119 | MP0000604_amyloidosis | 0.64910650 |
| 120 | MP0000015_abnormal_ear_pigmentation | 0.61624412 |
| 121 | MP0002060_abnormal_skin_morphology | 0.60812968 |
| 122 | MP0001243_abnormal_dermal_layer | 0.59958853 |
| 123 | MP0001915_intracranial_hemorrhage | 0.58361142 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.58010584 |
| 125 | MP0002693_abnormal_pancreas_physiology | 0.58003384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 4.23357790 |
| 2 | Myositis (HP:0100614) | 4.00809064 |
| 3 | Recurrent viral infections (HP:0004429) | 4.00476574 |
| 4 | Recurrent fungal infections (HP:0002841) | 3.83593044 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.82898872 |
| 6 | T lymphocytopenia (HP:0005403) | 3.80092542 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.75012722 |
| 8 | Abnormality of T cell number (HP:0011839) | 3.74917918 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.67095276 |
| 10 | Orchitis (HP:0100796) | 3.47381357 |
| 11 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.44909242 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.41597049 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.41347063 |
| 14 | Optic neuritis (HP:0100653) | 3.41347063 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.34243394 |
| 16 | IgM deficiency (HP:0002850) | 3.33296120 |
| 17 | Abnormality of T cells (HP:0002843) | 3.14180001 |
| 18 | Chronic otitis media (HP:0000389) | 3.14145445 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.11055458 |
| 20 | Agammaglobulinemia (HP:0004432) | 3.10618586 |
| 21 | Panhypogammaglobulinemia (HP:0003139) | 3.05912501 |
| 22 | Vasculitis (HP:0002633) | 3.05540223 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 2.99046290 |
| 24 | Meningitis (HP:0001287) | 2.97031087 |
| 25 | Arterial thrombosis (HP:0004420) | 2.96433338 |
| 26 | Cellulitis (HP:0100658) | 2.88075273 |
| 27 | Thrombocytosis (HP:0001894) | 2.87002243 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 2.86745410 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.86745410 |
| 30 | Prolonged bleeding time (HP:0003010) | 2.86478324 |
| 31 | Thyroiditis (HP:0100646) | 2.86036933 |
| 32 | Spontaneous hematomas (HP:0007420) | 2.84308605 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 2.81210181 |
| 34 | Pulmonary infiltrates (HP:0002113) | 2.76142251 |
| 35 | Inflammation of the large intestine (HP:0002037) | 2.71531575 |
| 36 | Periodontitis (HP:0000704) | 2.70377362 |
| 37 | Absent frontal sinuses (HP:0002688) | 2.70262773 |
| 38 | Chronic diarrhea (HP:0002028) | 2.69117910 |
| 39 | Eosinophilia (HP:0001880) | 2.67750215 |
| 40 | Acute myeloid leukemia (HP:0004808) | 2.67051425 |
| 41 | Abnormality of T cell physiology (HP:0011840) | 2.67009052 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 2.62848022 |
| 43 | Leukocytosis (HP:0001974) | 2.60721653 |
| 44 | Colitis (HP:0002583) | 2.54726520 |
| 45 | Keratoconjunctivitis sicca (HP:0001097) | 2.51043799 |
| 46 | Recurrent skin infections (HP:0001581) | 2.49035054 |
| 47 | IgA deficiency (HP:0002720) | 2.47182970 |
| 48 | Gingival bleeding (HP:0000225) | 2.46902907 |
| 49 | Abnormality of eosinophils (HP:0001879) | 2.46144646 |
| 50 | B lymphocytopenia (HP:0010976) | 2.45403584 |
| 51 | Abnormality of B cell number (HP:0010975) | 2.45403584 |
| 52 | Hemoptysis (HP:0002105) | 2.45069660 |
| 53 | Granulocytopenia (HP:0001913) | 2.44317060 |
| 54 | Chest pain (HP:0100749) | 2.43823387 |
| 55 | Encephalitis (HP:0002383) | 2.43477763 |
| 56 | Epistaxis (HP:0000421) | 2.42873536 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.41827779 |
| 58 | Abnormality of the prostate (HP:0008775) | 2.39667920 |
| 59 | Pustule (HP:0200039) | 2.39567921 |
| 60 | Aortic aneurysm (HP:0004942) | 2.36821402 |
| 61 | Lymphopenia (HP:0001888) | 2.35973972 |
| 62 | Severe combined immunodeficiency (HP:0004430) | 2.35020377 |
| 63 | Syringomyelia (HP:0003396) | 2.35019639 |
| 64 | Spinal cord lesions (HP:0100561) | 2.35019639 |
| 65 | IgG deficiency (HP:0004315) | 2.34500146 |
| 66 | Hematochezia (HP:0002573) | 2.31848603 |
| 67 | Nasal polyposis (HP:0100582) | 2.31489771 |
| 68 | Combined immunodeficiency (HP:0005387) | 2.29074896 |
| 69 | Petechiae (HP:0000967) | 2.26061897 |
| 70 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25346707 |
| 71 | Subacute progressive viral hepatitis (HP:0006572) | 2.23730266 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.22635280 |
| 73 | Peritonitis (HP:0002586) | 2.21803736 |
| 74 | Spondylolisthesis (HP:0003302) | 2.21134105 |
| 75 | Abnormality of the nasal mucosa (HP:0000433) | 2.20877939 |
| 76 | Gingivitis (HP:0000230) | 2.20500524 |
| 77 | Gastrointestinal stroma tumor (HP:0100723) | 2.20269591 |
| 78 | Viral hepatitis (HP:0006562) | 2.20216983 |
| 79 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.19497367 |
| 80 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.17101501 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16966923 |
| 82 | Pulmonary embolism (HP:0002204) | 2.16062428 |
| 83 | Osteomyelitis (HP:0002754) | 2.14305094 |
| 84 | Volvulus (HP:0002580) | 2.13270917 |
| 85 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.13071757 |
| 86 | Osteolytic defects of the hand bones (HP:0009699) | 2.13071757 |
| 87 | Abnormality of the endocardium (HP:0004306) | 2.10974586 |
| 88 | Slow saccadic eye movements (HP:0000514) | 2.10038751 |
| 89 | Interstitial pulmonary disease (HP:0006530) | 2.08006159 |
| 90 | Obstructive lung disease (HP:0006536) | 2.07768730 |
| 91 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07768730 |
| 92 | Long eyelashes (HP:0000527) | 2.07099020 |
| 93 | Abnormality of macrophages (HP:0004311) | 2.02215415 |
| 94 | Hyporeflexia of lower limbs (HP:0002600) | 2.01128939 |
| 95 | Urticaria (HP:0001025) | 1.97981825 |
| 96 | Abnormality of the pleura (HP:0002103) | 1.97977652 |
| 97 | Increased IgE level (HP:0003212) | 1.96662757 |
| 98 | Hypoplasia of the thymus (HP:0000778) | 1.95879390 |
| 99 | Papilledema (HP:0001085) | 1.95081704 |
| 100 | Neonatal hypoglycemia (HP:0001998) | 1.94811868 |
| 101 | Abnormality of the peritoneum (HP:0002585) | 1.94031229 |
| 102 | Abnormal platelet volume (HP:0011876) | 1.93307889 |
| 103 | Stomatitis (HP:0010280) | 1.91388689 |
| 104 | Amaurosis fugax (HP:0100576) | 1.90843554 |
| 105 | Difficulty running (HP:0009046) | 1.90841390 |
| 106 | Autoimmune hemolytic anemia (HP:0001890) | 1.90608714 |
| 107 | Lymphoma (HP:0002665) | 1.90302134 |
| 108 | Alveolar cell carcinoma (HP:0006519) | 1.90195458 |
| 109 | Muscle fiber splitting (HP:0003555) | 1.90052366 |
| 110 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.88576406 |
| 111 | Impaired platelet aggregation (HP:0003540) | 1.88134873 |
| 112 | Abnormal platelet function (HP:0011869) | 1.88134873 |
| 113 | Lip pit (HP:0100267) | 1.86980573 |
| 114 | Emphysema (HP:0002097) | 1.86744062 |
| 115 | Papilloma (HP:0012740) | 1.86730843 |
| 116 | Verrucae (HP:0200043) | 1.86730843 |
| 117 | Prostate neoplasm (HP:0100787) | 1.86273649 |
| 118 | Stomach cancer (HP:0012126) | 1.85203201 |
| 119 | Gangrene (HP:0100758) | 1.83860324 |
| 120 | Increased IgM level (HP:0003496) | 1.83441592 |
| 121 | Vertigo (HP:0002321) | 1.79820305 |
| 122 | Joint swelling (HP:0001386) | 1.76939945 |
| 123 | Fatigue (HP:0012378) | 1.74739811 |
| 124 | Restrictive lung disease (HP:0002091) | 1.74350994 |
| 125 | Conjunctival telangiectasia (HP:0000524) | 1.71533310 |
| 126 | Narrow palate (HP:0000189) | 1.70431793 |
| 127 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.69769419 |
| 128 | Amyloidosis (HP:0011034) | 1.68140109 |
| 129 | Genetic anticipation (HP:0003743) | 1.67436921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.09321042 |
| 2 | TXK | 3.55866253 |
| 3 | MAP3K14 | 2.94425177 |
| 4 | JAK3 | 2.75728279 |
| 5 | KIT | 2.24541340 |
| 6 | IRAK4 | 2.23883749 |
| 7 | TYK2 | 2.15341712 |
| 8 | IKBKE | 2.12944251 |
| 9 | CDK12 | 2.12302499 |
| 10 | TEC | 2.11260009 |
| 11 | ITK | 2.06378820 |
| 12 | FGFR3 | 2.00265701 |
| 13 | ZAP70 | 1.93464220 |
| 14 | STK10 | 1.90640645 |
| 15 | BTK | 1.90338200 |
| 16 | IKBKB | 1.89053473 |
| 17 | JAK1 | 1.82584960 |
| 18 | TBK1 | 1.81772658 |
| 19 | MAP2K3 | 1.81120542 |
| 20 | TGFBR2 | 1.79668559 |
| 21 | IRAK3 | 1.78430792 |
| 22 | PRPF4B | 1.76579268 |
| 23 | TAOK3 | 1.75370891 |
| 24 | CHUK | 1.71897225 |
| 25 | CSF1R | 1.55457618 |
| 26 | FLT3 | 1.49186168 |
| 27 | FGFR4 | 1.47007690 |
| 28 | SYK | 1.41335576 |
| 29 | ERN1 | 1.40460338 |
| 30 | NLK | 1.39496080 |
| 31 | PIM1 | 1.32837979 |
| 32 | STK24 | 1.31039884 |
| 33 | GRK6 | 1.29069608 |
| 34 | CSK | 1.26761923 |
| 35 | MARK2 | 1.26035733 |
| 36 | LCK | 1.24480757 |
| 37 | CDC42BPA | 1.23650702 |
| 38 | FGR | 1.23261845 |
| 39 | HCK | 1.20847664 |
| 40 | AKT3 | 1.19816558 |
| 41 | TRPM7 | 1.19677885 |
| 42 | MAP3K3 | 1.18347123 |
| 43 | MAP3K10 | 1.17449945 |
| 44 | BLK | 1.17280646 |
| 45 | NEK9 | 1.10070997 |
| 46 | BMPR2 | 1.08038064 |
| 47 | RPS6KA4 | 1.05762537 |
| 48 | NUAK1 | 1.02538957 |
| 49 | STK4 | 1.02245553 |
| 50 | EPHB1 | 1.01783166 |
| 51 | TIE1 | 1.01556806 |
| 52 | CAMK1D | 1.00584251 |
| 53 | SIK3 | 1.00241541 |
| 54 | WNK1 | 0.98544483 |
| 55 | MAP3K13 | 0.97704371 |
| 56 | BRD4 | 0.95288978 |
| 57 | EEF2K | 0.94761764 |
| 58 | EPHA3 | 0.91264328 |
| 59 | MELK | 0.90408982 |
| 60 | INSRR | 0.90088196 |
| 61 | MAPK12 | 0.90016413 |
| 62 | MAP3K1 | 0.88180808 |
| 63 | RIPK4 | 0.86535377 |
| 64 | LYN | 0.85795806 |
| 65 | MAP3K6 | 0.85717245 |
| 66 | PTK2B | 0.85388685 |
| 67 | MAP3K2 | 0.81218944 |
| 68 | OBSCN | 0.81207662 |
| 69 | SGK223 | 0.80351728 |
| 70 | SGK494 | 0.80351728 |
| 71 | PDK1 | 0.79667869 |
| 72 | HIPK2 | 0.79626140 |
| 73 | MATK | 0.76493301 |
| 74 | JAK2 | 0.75441376 |
| 75 | CDK6 | 0.75326242 |
| 76 | CLK1 | 0.74221103 |
| 77 | ZAK | 0.73932841 |
| 78 | CAMK1G | 0.73900444 |
| 79 | FRK | 0.73143801 |
| 80 | LRRK2 | 0.69995733 |
| 81 | PRKCQ | 0.68436315 |
| 82 | YES1 | 0.67152983 |
| 83 | MAPK7 | 0.66589386 |
| 84 | MARK3 | 0.65748096 |
| 85 | RET | 0.64525006 |
| 86 | TTN | 0.63407542 |
| 87 | MAPK11 | 0.63321894 |
| 88 | PTK6 | 0.62938882 |
| 89 | ACVR1B | 0.62139525 |
| 90 | CAMKK2 | 0.61219031 |
| 91 | PIK3CA | 0.61186010 |
| 92 | STK3 | 0.60975430 |
| 93 | MST4 | 0.60898551 |
| 94 | SGK3 | 0.58486669 |
| 95 | CDK9 | 0.57372476 |
| 96 | PRKCH | 0.57149720 |
| 97 | PDGFRB | 0.56316518 |
| 98 | PRKAA2 | 0.55799147 |
| 99 | PRKD2 | 0.55713565 |
| 100 | DMPK | 0.54427949 |
| 101 | RIPK1 | 0.53427130 |
| 102 | TGFBR1 | 0.52700478 |
| 103 | CDK4 | 0.52625855 |
| 104 | STK11 | 0.52012952 |
| 105 | EGFR | 0.51050908 |
| 106 | ERBB2 | 0.50119535 |
| 107 | GRK7 | 0.49987000 |
| 108 | STK38 | 0.49981922 |
| 109 | PDPK1 | 0.49149518 |
| 110 | PKN2 | 0.48676462 |
| 111 | RPS6KA6 | 0.46709495 |
| 112 | FYN | 0.46377226 |
| 113 | SGK2 | 0.45999474 |
| 114 | MAP3K7 | 0.45810389 |
| 115 | IGF1R | 0.45263175 |
| 116 | TNK2 | 0.45024624 |
| 117 | PIM2 | 0.44229598 |
| 118 | MAP3K5 | 0.44167754 |
| 119 | NEK6 | 0.44052096 |
| 120 | IRAK2 | 0.43753911 |
| 121 | MAPKAPK2 | 0.43702021 |
| 122 | ATR | 0.43546646 |
| 123 | PRKD1 | 0.43114906 |
| 124 | TRIB3 | 0.40729738 |
| 125 | IRAK1 | 0.39920267 |
| 126 | FES | 0.38485219 |
| 127 | RPS6KB2 | 0.37477071 |
| 128 | PIK3CG | 0.37465041 |
| 129 | MAPK3 | 0.37139908 |
| 130 | SIK1 | 0.37053297 |
| 131 | PASK | 0.35421817 |
| 132 | RPS6KA5 | 0.35383771 |
| 133 | ABL1 | 0.35284065 |
| 134 | CAMK4 | 0.34324441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.22666516 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66852686 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.55921270 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55592547 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.41611828 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.38222717 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.29930394 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20760112 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11902852 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09230820 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.03842211 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.01686986 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.90016852 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.88959711 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79910026 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.77840076 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.77220185 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74907727 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69710468 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65106163 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63144932 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.59262428 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.59260883 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54568375 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48933310 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.45221378 |
| 27 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.42139649 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.38692208 |
| 29 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38064263 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.36822025 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32333021 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.30170597 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.28128557 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.26864590 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24793020 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23259008 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.22348269 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.21935657 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.20249082 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.17766092 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17387619 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.15329910 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.14667309 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11180643 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.07693149 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06170635 |
| 47 | Asthma_Homo sapiens_hsa05310 | 1.04382201 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03290061 |
| 49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99033237 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97571175 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95875506 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.93890491 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.91837631 |
| 54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.89764988 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 0.88284695 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.87715043 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87467933 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.84260082 |
| 59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.82058585 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78794640 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78138493 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77931017 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77688438 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76844200 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.75816211 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72155108 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.71539498 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71461086 |
| 69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71056768 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71012936 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.70942270 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70592020 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.70437923 |
| 74 | Base excision repair_Homo sapiens_hsa03410 | 0.70014001 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69814483 |
| 76 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69436597 |
| 77 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67879580 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.67091262 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66588432 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66397198 |
| 81 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65666141 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64562984 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.64158649 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.62097540 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61081903 |
| 86 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59800996 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59500775 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58412217 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.56922464 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55631916 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.53963409 |
| 92 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53565941 |
| 93 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.53393777 |
| 94 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51501499 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.51390317 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.51176973 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.49549172 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.49257930 |
| 99 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48322405 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47731371 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46989995 |
| 102 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46672354 |
| 103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46137771 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45966169 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45226446 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44702543 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44597344 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42696402 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41982904 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41839295 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39238098 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.38698238 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37723383 |
| 114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37249926 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35603032 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34790198 |
| 117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.34714319 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.34503007 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34469786 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33978120 |
| 121 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33044161 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32894839 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32344606 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31816054 |

